American Journal of Pharmacy and Health Research

AJPHR

2321-3647

10.5281/zenodo.17875587

AJPHR1310001

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

Biji

Dr. Namitha Rachel

Mathew

Prof. Dr. S.K

Josey

Dr. Dhanu

John

Dr. Joseph

10 01 2025

13 10

ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.

SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.